Michael M. Strage
Founder bei ANGIOGENEX, INC.
Aktive Positionen von Michael M. Strage
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANGIOGENEX, INC. | Director/Board Member | 01.01.2007 | - |
| Chief Operating Officer | 01.01.2007 | - | |
| Founder | 31.03.1999 | - | |
| Investor Relations Contact | - | - |
Karriereverlauf von Michael M. Strage
Ehemalige bekannte Positionen von Michael M. Strage
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hancock Rothert & Bunshoft LLP
 Hancock Rothert & Bunshoft LLP Miscellaneous Commercial ServicesCommercial Services Part of Duane Morris LLP, Hancock Rothert & Bunshoft LLP is a legal advisory services provider. The private company is based in Los Angeles, CA. Hancock Rothert & Bunshoft was acquired by Duane Morris LLP on January 01, 2006. | Corporate Officer/Principal | - | - |
Axonyx, Inc.
 Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | Chief Administrative Officer | 01.01.1996 | - |
| Founder | 01.01.1996 | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | Health Technology |
Hancock Rothert & Bunshoft LLP
Hancock Rothert & Bunshoft LLP Miscellaneous Commercial ServicesCommercial Services Part of Duane Morris LLP, Hancock Rothert & Bunshoft LLP is a legal advisory services provider. The private company is based in Los Angeles, CA. Hancock Rothert & Bunshoft was acquired by Duane Morris LLP on January 01, 2006. | Commercial Services |
AngioGenex, Inc.
 AngioGenex, Inc. Pharmaceuticals: MajorHealth Technology AngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra in March 1999 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Michael M. Strage
- Erfahrung
